EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiological characteristics of lorcainide, a new antiarrhythmic drug


, : Electrophysiological characteristics of lorcainide, a new antiarrhythmic drug. International Journal of Clinical Pharmacology, Therapy, and Toxicology 24(1): 26-29

The electrophysiological characteristics and the antiarrhythmic indication areas of lorcainide were studied by using electrophysiological investigations and clinical studies in patients suffering from sustained arrhythmias. According to the data of the arrhythmia analyses (30 patients) the most important electrophysiological effects of lorcainide are: increase of the effective refractory period of the atria and ventricles; prolongation of the conduction time in the His bundle; prolongation of the refractory period and conduction of the accessory pathways. In the course of clinical studies (55 patients) lorcainide proved to be very effective in treating ventricular arrhythmias and preventing or disrupting ventricular tachyarrhythmic attacks. Lorcainide has a very promising antiarrhythmic effect in the suppression of tachyarrhythmias with accessory pathway conduction, too.


Accession: 005349484

PMID: 3957486

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Bär, F.W.; Farré, J.; Ross, D.; Vanagt, E.J.; Gorgels, A.P.; Wellens, H.J., 1981: Electrophysiological effects of lorcainide, a new antiarrhythmic drug. Observations in patients with and without pre-excitation. The electrophysiological effects of the intravenous administration of a new antiarrhythmic drug, lorcainide, were evaluated by programmed electrical stimulation of the heart in 23 patients with atrioventricular conduction disturbances (four patien...

Shigenobu, K.; Atoda, H.; Asano, T.; Kasuya, Y., 1980: Electrophysiological effects of a new antiarrhythmic agent, lorcainide, on the isolated cardiac muscle fiber as compared with disopyramide. Electrophysiological effects of a new antiarrhythmic agent, lorcainide, were studied in the isolated guinea pig ventricular myocardium and were compared with those of disopyramide; some of the experiments were also made by using the canine ventric...

Kong R Z.; Xie Y X., 1990: Improved synthesis of antiarrhythmic drug lorcainide. An improved six-step synthetic process of lorcainide, an antiarrhythmic drug, was reported. The catalytic addition reaction of isopropylamine and methyl acrylate had an advantage of no reaction solvent and shorter reaction time.

Somani P.; Temesy Armos P.N.; Leighton R.F.; Goodenday L.S.; Fraker T.D.Jr, 1984: Hyponatremia in patients treated with lorcainide a new antiarrhythmic drug. The effects of iorcainide, a new antiarrhythmic drug, on serum electrolytes and osmolality are described in a series of 33 patients with organic heart disease and complex ventricular arrhythmias treated with lorcainide. In 8 patients, a mean decre...

Somani, P.; di Giorgi, S., 1980: Resistant ventricular arrhythmias treated with lorcainide, a new antiarrhythmic drug. A 68-year-old patient developed increasingly frequent episodes of ventricular and supraventricular arrhythmias over the past five years. During the last 12 months, he was admitted to the hospital on several occasions with complex arrhythmias inclu...

Somani, P., 1981: Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders. Lorcainide, a new class I antiarrhythmic drug, was administered intravenously to 10 patients with a documented history of ventricular arrhythmias. Three patients had arrhythmias resistant to all conventional antiarrhythmic drugs; in all other pati...

Somberg, J.C.; Torres, V., 1984: New directions in antiarrhythmic drug therapy: the development of a promising new agent, lorcainide. American Journal of Cardiology 54(4): 1b-1b

Senges, J.; Rizos, I.; Brachmann, J.; Gao, T.L.; Lengfelder, W.; Kübler, W., 1982: Arrhythmogenic effects of toxic concentrations of the antiarrhythmic drug lorcainide on the isolated canine ventricle. The effect of the new antiarrhythmic drug lorcainide was studied on the specialized conducting system of isolated canine ventricle. Transmembrane action potentials were recorded simultaneously from three subendocardial sites within the ventricular...

Kimura, T.; Nakazawa, M.; Imai, S., 1986: Electrophysiological effects of bunaftine, an antiarrhythmic drug, on action potential characteristics in ventricular muscle preparations. The electrophysiological effects of bunaftine were studied using the glass microelectrode technique. Bunaftine at 1, 5 and 10 mg/l produced a concentration-dependent depression of the maximum rate of rise of the action potential in guinea pig papi...

Simon, V.; Somani, P., 1982: Rapid and simple method for determination of lorcainide, a new antiarrhythmic drug, and its major metabolite, norlorcainide, by high-performance liquid chromatography. Journal of Chromatography 231(2): 478-484